On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > ACADEMIA
ACADEMIA
- Cancer Researchers Call for Academia-Industry Collaboration via Japan NIH
December 9, 2014
- 22 Seeds Supported by Drug Discovery Support Network So Far: Dr Kurebayashi of NIBIO
December 9, 2014
- AIDS Treatment Extends Lives, but Many Problems Remain: Dr Mitsuya
December 1, 2014
- J-ARF Moving Into Full Gear as Academic Research Organization
December 1, 2014
- Next Year to See “Dawn of New Age” of Interferon-Free Hepatitis C Treatment: Dr Kumada
November 28, 2014
- Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official
November 27, 2014
- J-CLEAR’s Kuwajima Criticizes Plan to Legally Regulate Clinical Research
November 12, 2014
- ICH-GCP Compliance Obligatory for Clinical Studies Conducted by Chiba University
October 28, 2014
- Chiba University Issues Warning to Prof. Involved in VART Study
October 28, 2014
- JSH to Draft Guidelines on Clinical Research with Company Funding
October 21, 2014
- St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
- Japanese Society of Hypertension Announces Resignation of President
October 1, 2014
- Rivaroxaban as Safe and Effective as Standard Therapy in Japanese DVT Patients: J-EINSTEIN DVT Study
September 30, 2014
- Safety and Efficacy of Secukinumab Confirmed for Psoriasis in Japanese Patients
September 24, 2014
- Dr Yui Poses Questions on Dabigatran Analysis Model on BMJ
September 9, 2014
- Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
- Kyoto University, Astellas Aim to Develop Immunological Disease Cures, 11 Target Molecules Now under Screening
August 21, 2014
- Chiba Univ. Once Again Advises Authors to Withdraw Papers from VART Study
August 19, 2014
- Japanese Circulation Society Issues Warning Letter to Dr Matsubara and Co-Authors in Connection with Diovan Scandal
August 15, 2014
- JSH to Adopt Tougher COI Rule after Panel Said Novartis’s Involvement in SIGN Trial Should Have Been Disclosed at Conference
August 5, 2014
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…